Oropharyngeal shedding of herpesviruses before and after BNT162b2 mRNA vaccination against COVID-19

Title
Oropharyngeal shedding of herpesviruses before and after BNT162b2 mRNA vaccination against COVID-19
Authors
Keywords
COVID-19 vaccine, BNT162b2, Pfizer, BioNTech, Bell's palsy, Facial palsy, Herpes virus, Herpes simplex virus, Varicella zoster virus, Epstein Barr virus, Cytomegalovirus, Human herpes virus 6, Human herpes virus 7, Reactivation, Oropharyngeal shedding
Journal
VACCINE
Volume 39, Issue 40, Pages 5729-5731
Publisher
Elsevier BV
Online
2021-08-30
DOI
10.1016/j.vaccine.2021.08.088

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now